life sciences

Thought Leader Select’s Meade to Address ExL Pharma KOL Conference

Thought Leader Select continues with a busy summer schedule of conference sponsorships, with the company’s support of ExL Pharma’s Fifth KOL Relationship Summit in Philadelphia.  Paul Meade, founder and President of Thought Leader Select, will address attendees at one of the must-attend events for American life sciences companies, coming on the heels of the company’s …

Thought Leader Select’s Meade to Address ExL Pharma KOL Conference Read More »

Global Biopharma Re-engages Thought Leader Select to Support Canadian KOL, Centers of Excellence Initiatives in Head and Neck Cancer

March 27, 2014 (CHAPEL HILL, NC) Thought Leader Select, a firm dedicated to supporting life sciences companies in their collaborative work with the medical community, has begun a strategic engagement in the area of head and neck cancer for the Canadian division of a top global biopharmaceutical company. The client company chose North Carolina’s Thought Leader …

Global Biopharma Re-engages Thought Leader Select to Support Canadian KOL, Centers of Excellence Initiatives in Head and Neck Cancer Read More »

Thought Leader Select Announces Hiring of Carol Younkin

February 4, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries of pharmaceuticals, biotechnology, medical devices, and diagnostics, announces the hiring of Carol Younkin to a leadership position in its in-house research group. Younkin takes on the research manager role at Thought Leader Select after nearly two …

Thought Leader Select Announces Hiring of Carol Younkin Read More »

The Secret to Sound KOL Research—It’s Not a Data Dump

Industry Insights from Brian Castle There are many ways that life science companies approach finding the right key opinion leaders in medicine to collaborate on next-generation treatments. Some have the privilege of retaining staff members with decades of experience, during which they get to know the top doctors in their therapeutic area or disease state.  …

The Secret to Sound KOL Research—It’s Not a Data Dump Read More »